Overall, our findings reveal a novel role of STAT6 in ALL cells and validate multiple effective strategies for targeting STAT6 (Fig. 5F) and thus provide potential new avenues for overcoming of Ara-C resistance in future ALL treatment. This evidence concerns the gene STAT6 and acute lymphoblastic leukemia.